1Juliane K. Unger, Claudia Haltern, et al. Albumin and hydroxyethyl starch 130 kDa/0. 4 improve filter clearance and haemocompatibility in haemo-and plasmafiltration - an in vitro study [J]. Nephrol Dial Transplant,2005,20(9 ) :1922-1931.
2Gerd Haisch,MD,Joachirn Boldt,MD,et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0. 4) on coagulation in patients undergoing major abdominal surgery[J]. Anesth Analg,2001,92( 3 ) :565-571.
3Joachim Boldt, MD, Tomten B, et al. Kidney specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass[J]. Ane Ana,2003,97(6) :1582-1589.
4Joachim Boldt MD, Hans JP. Intravascular volume Replacement Therapy with Synthetic Colloids:Is There an Influence on Renal Function? [J]. Anesth Analg,2003,96(2) :376-382.
5Thomas A. Neff MD,Martin D,et al. Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in patients with severe head injury[J]. nesth Analg,2003,96(5) :1453-1459.
6Stefan M, Kasper MD. Large dose hydroxyethyl starch 130/0. 4 does not increase blood loss and transfusion Requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0. 5 at recommended doses [ J ]. Anesthesiology, 2003,99 ( 1 ) :42-47.
7Mauritz W, Schimetta W, Oberreither S. Are hypertonic hyperoncotic solutions safe for prehospital small-volume resuscitation? [J]. Eur J Emerg Med,2002, (4) :315-319.
8Orlinsky M, Shoemaker W, Reis ED. Current controversies in shock and resuscitation [ J ]. Surg Clin North Am, 2001,81 ( 6 ) : 1217-1262.
9Moretti EW, Robertson KM, et al. Intraoperative colloid adminis-tration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration [J]. J An Aria,2003,96(2) :611-617.
10Wilkes MM, Navickis RJ. Patient survival after human albumin administration :a meta-analysis of randomized, controlled trails [J]. Ann Intern Med,2001,135(3) :149-164.
